(Q36237974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Scott Bell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Shawn D. Aaron

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

J K Block

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

K L Vandemheen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

E Tullis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S Doucette

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

D Haase

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Y Berthiaume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

N Brown

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

P Wilcox

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

P Bye

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M Noseworthy

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

L Pedder

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A Freitag

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

N Paterson

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

14 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

969-974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

27 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Defining a pulmonary exacerbation in cystic fibrosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Predictive 5-year survivorship model of cystic fibrosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Inhaled corticosteroids for cystic fibrosis.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

The cost of medical care for patients with cystic fibrosis in a health maintenance organization

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Gender gap in cystic fibrosis mortality

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

The effect of infective exacerbations on sleep and neurobehavioral function in cystic fibrosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2121166

Prediction of Mortality in Patients with Cystic Fibrosis

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16844728

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16844728

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.2006.061366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16844728%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference